talazoparib,enzalutamide
pfizer,astellas,astrazeneca,merck,gsk,clovis oncology
['prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'talzenna', 'talapro-2', '$pfe']
and here we go: #gu23 discussant dr elena castro casts serious doubt on $pfe talapro-2 presenter's claim that talzenna should be used in 1l prostate cancer "regardless of hrr status" 
Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.